BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh AK, Verma S, Kumar-M P, Soni H, Sharma S, Patil A, Sharma V. Appropriate chemopreventive strategy for anti-tubercular therapy related liver injury is unsettled: Results from a systematic review and network meta-analysis.Expert Rev Clin Pharmacol. 2020;13:1253-1262. [PMID: 33043729 DOI: 10.1080/17512433.2020.1835468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo S, Bai X, Liu Y, Shi S, Wang X, Zhan Y, Kang X, Chen Y, An H. Inhibition of TMEM16A by Natural Product Silibinin: Potential Lead Compounds for Treatment of Lung Adenocarcinoma. Front Pharmacol 2021;12:643489. [PMID: 33935737 DOI: 10.3389/fphar.2021.643489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Woo SM, Davis WD, Aggarwal S, Clinton JW, Kiparizoska S, Lewis JH. Herbal and dietary supplement induced liver injury: Highlights from the recent literature. World J Hepatol 2021; 13(9): 1019-1041 [PMID: 34630872 DOI: 10.4254/wjh.v13.i9.1019] [Reference Citation Analysis]